Market Research Blog – Page 1988 – New Product Development

Point of Care Molecular Diagnostics Market Set to Surge at 9.7% CAGR, Reaching US$11.1 Billion by 2033 | FMI Study

The Point of Care Molecular Diagnostics Market is poised for a remarkable expansion, fueled by the increasing demand for rapid and accurate diagnoses at the patient’s bedside. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is expected to skyrocket from a valuation of US$4.4 billion in 2023 to a staggering US$11.1 billion by 2033. This translates to a robust Compound Annual Growth Rate (CAGR) of 9.7%, signifying a significant shift towards faster and more convenient diagnostic testing within the healthcare landscape.

The extraordinary trajectory of this industry indicates a growing demand for point-of-care molecular diagnostics, which is being driven by the increasing prevalence of infectious and chronic diseases. Cardiovascular disease, diabetes, and the continued issues posed by COVID-19 have all contributed to the increased demand for rapid and precise diagnostic treatments.

Request a Sample Copy of the Report Now
https://www.futuremarketinsights.com/reports/sample/rep-gb-14279

The growing advanced technology, diagnostic tests, preventive medicine, and knowledge of molecular mechanisms are driving the market growth. Furthermore, the adoption of the Global Point of Care Molecular Diagnostics Industry by laboratory specialists for sequencing DNA & multi-gene is expanding the market size. These diagnostics rapidly show the results with accuracy and are estimated to increase the sales of point-of-care molecular diagnostics.

Increasing respiratory, gastrointestinal, and sexually transmitted diseases are advancing the market growth. Emerging economies, government initiatives, and low-cost POC molecular diagnostics are the prime factors that propel market opportunities.

Factors Restraining the Global Point of Care Molecular Diagnostics Industry Growth

The market is going through a growth decline due to a few factors which are given below:

The dearth of consciousness about healthcare products, and poor penetration of advanced healthcare devices restrain market growth. The unavailability of advanced devices and the absence of government policies must gain market growth in developing countries.

Which Technology Category Booms the Point of Care Molecular Diagnostics Market Growth?

The RT-PCR category dominates the global market with its remarkable CAGR of 9.2% during the foreseen time. The adoption of RT-PCR is rising due to the rise in tests such as genomics, COVID-19, proteomics, and others. It is a real-time system that shows results immediately, has high sensitivity, and costs efficiently. Due to the significant growth of infectious patients, healthcare providers are accelerating the demand for RT-PCR to provide patients with relevant data immediately.

Point of Care Molecular Diagnostics Market Key Takeaways:

The Global point-of-care Molecular Diagnostics Industry is expected to have a valuation of US$ 11.1 billion by 2033.
With a CAGR of 9.7%, the global market will increase from 2022 to 2033.
The United States market is anticipated to capture a CAGR of 9.5% through 2033.
With a CAGR of 8.8%, the United Kingdom market significantly uplifts during the forecast period.
China’s market is expected to expand at a CAGR of 9.1% over the forecast period.
Japan’s market is likely to capture a CAGR of 8.2% from 2023 to 2033.

Who is winning?

Key players fragment the global market by contributing an impressive role. These players are bringing new ideas and adapting them to build advanced products, which in turn surging market opportunities. Growing technologies, including Artificial Intelligence and the Internet of Things, have surpassed market growth in recent years.

By accepting these technologies, key players welcome better detection machines and equipment as per patients’ requirements. They further follow several effective marketing strategies such as partnerships, mergers, acquisitions, agreements, and product launches.

Recent Developments in the Point of Care Molecular Diagnostics Market:

In Feb 2022, Sense Biodetection signed an agreement with Una Health to distribute COVID-19 testing equipment.
In Dec 2021, FIND Company invested a valuation of US$ 21 million in S.D. Biosensor, Biomeme, Quaife, and Bioneer for manufacturing, developing, and launching an affordable COVID-19 testing detector.
A healthcare provider BioMérieux agreed to partner with Africa Medical Supplies Platform in Oct 2020 to supply premium quality COVID-19 diagnostic solutions.
Abbott Laboratories announced its new COVID-19 detection product which can deliver results within minutes, in March 2020.
In Oct 2018, QIAGEN agreed to enhance its portfolio with STAT-Dx to provide its customers with a next-generation PCR system.

Level Up Your Market Understanding – Purchase Now!
https://www.futuremarketinsights.com/checkout/14279

Point of Care Molecular Diagnostics Market Segmentation by Category

By Products & Services:

Assays & Kits
Instruments &Analyzers
Software & Services

By Technology:

RT-PCR
INAAT
Other Technologies

By Application:

Respiratory Diseases
Sexually Transmitted Diseases
Hospital-acquired Infections
Cancer
- Hepatitis
Gastrointestinal Disorders
Other Applications

By End User:

Physicians’ Offices
Hospitals & ICUs
Research Institutes
Other End Users

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Sepsis Diagnostics Market Gears Up for 8.1% CAGR, Reaching US$1.2 Billion by 2033 | FMI Study

The Sepsis Diagnostics Market is on the rise, fueled by a growing recognition of this life-threatening condition and significant advancements in diagnostic technology. According to a recent market analysis by Future Market Insights (FMI), a leading market research firm, the market is poised for a robust trajectory. Currently valued at US$561.2 million in 2023, it’s expected to climb at a compelling Compound Annual Growth Rate (CAGR) of 8.1% over the next decade. This positive outlook signifies a potential market valuation of US$1.2 billion by 2033.

Several variables are driving demand for sepsis diagnostics, contributing to this large increase. The growing prevalence of antibiotic-resistant bacterial strains, a rapidly aging global population, and an increase in hospital-acquired illnesses have heightened the demand for better diagnostic solutions. Notably, the spike in product approvals for sepsis diagnosis is projected to drive up demand for cutting-edge diagnostics in the industry.

Despite the optimistic trajectory, the industry faces challenges that warrant attention. The shortage of experienced specialists for sepsis diagnosis poses a notable obstacle, compounded by a lack of awareness and the persistent reliance on conventional processes during antibiotic production, all identified as factors impacting the sales of sepsis diagnostics.

However, the market’s potential is buoyed by positive indicators in developing markets. The increasing incidence of newborn umbilical cord infections and a rise in surgical procedures in these regions provide a favorable landscape for the growth of sepsis diagnostics.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14272

HAIs, also known as nosocomial infections, are a leading source of morbidity and mortality in hospitals around the world. Urinary tract infections, pneumonia, and sepsis are the most frequent hospital-acquired infections (HAIs). In addition, in immunocompromised individuals, aged patients, and people with chronic conditions, HAIs can cause sepsis. Because of the significant rise in HAIs around the world, demand for sepsis diagnostic devices is projected to expand in the future years.

Sepsis is a complex condition to detect, and even a one-minute delay in antibiotic delivery increases the chance of death by 7.6% in septic shock patients with hypertension. As a result of the emerging trends in the Global Sepsis Diagnostics Industry, there is a greater need for quick sepsis detection to avoid antibiotic therapy delays in sepsis patients.

Many sepsis diagnostic companies are growing their product offerings in point-of-care technologies, which can quickly identify sepsis, cut down on diagnosis time, and improve life expectancy after sepsis.

Key Takeaways from the Sepsis Diagnostics Market

Attributed to the presence of a larger consumer population in developing markets such as India and China, the Asia Pacific region of rapid sepsis diagnostics is expected to grow profitably over the forecast period.
The Global Sepsis Diagnostics Market adoption trends indicate North America is likely to generate more than $200 million in revenue by the end of 2026. The sepsis diagnostics companies in the region are growing due to well-established healthcare infrastructure and increased usage of innovative products. Septic poisoning is also one of the leading causes of death in the United States.
As per the sepsis diagnostics market analysis, microbiology technology is likely to gain traction. Microbiology is expected to generate more than $200 million in income by 2026.
By product, the sepsis diagnostics market opportunities are divided into blood culture media, assays & reagent kits, devices, and software. The blood culture media segment held the most significant market share during the forecast period. This growth can be ascribed to a rise in blood culture media as a sepsis diagnostics device.

“Sepsis diagnostics devices are expensive, limiting the growth of this industry. Additionally, in certain countries, there are no clear guidelines for the treatment of sepsis, and there is a lack of awareness about the repercussions of sepsis if it is not treated effectively.”

Competitive Landscape Organizations in the global quality articulation market are consolidating and acquiring systems to gain a competitive advantage and generate significant profits. On the other hand, some players benefit from significant new work systems to gain a competitive advantage in the Global Sepsis Diagnostics Industry statistics.

Cytovale Inc. and the Biomedical Advanced Research and Development Authority, or BARDA, announced cooperation in April 2020 to increase the use of Cytovale’s Rapid Sepsis Diagnostic System for identifying sepsis in patients with probable respiratory infections, such as COVID-19.
Immunexpress announced a quick SeptiCyte, a one-hour molecular diagnostic test for sepsis, on Biocartis’ Idylla platform in Europe in October 2020. This is one of the first deeply integrated, immune response-based diagnostics to help clinicians diagnose sepsis and Global Sepsis Diagnostics Industry analysis.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/14272

Sepsis Diagnostics Market Key Segments

By Product:

Blood Culture Media
Assays & Reagents
Instruments, and Software

By Technology:

Blood Culture
Immunoassays
Molecular Diagnostics
Flow Cytometry
Microfluidics
Biomarkers

By Method:

Automated Diagnostics
Conventional Diagnostics

By Pathogen:

Bacterial Sepsis
Fungal Sepsis
Viral Sepsis
Others

By Test Type:

Laboratory Tests
Point-of-Care Tests

By End User:

Hospitals and Specialty Clinics
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Electronic Manufacturing Services Market Poised to Achieve Remarkable Growth, Exceeding US$ 859.96 Billion by 2033

The global Electronic Manufacturing Services (EMS) market is poised for substantial growth, fueled by the escalating demand and robust sales of consumer electronics. According to the latest market projections, the Electronic Manufacturing Services market is anticipated to reach a valuation of US$ 541,554.4 million by the end of 2023.

This market is forecasted to experience a steady Compound Annual Growth Rate (CAGR) of 4.7% during the period 2023-2033, ultimately soaring to a total value of approximately US$ 859,959.3 million by 2033.

Electronic Manufacturing Services has received a warm welcome in a variety of industries since its introduction, owing to its diverse applications in areas such as control framework for radar observation, mission control PC in aeroplanes and satellites, and so on.

Unlock Precious Insights: Request Our Sample Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-5870

Electronic Manufacturing Services Market: Drivers and Challenges

An increased demand and sales of electronics, especially consumer electronics, is witnessed globally which is further expected to rise in the forecast period. This demand correspondingly increases the adoption and implementation of Electronic Manufacturing Services, which as a result, drives the global Electronics Manufacturing Services market.

In addition to this, implementation and utilization of Electronic Manufacturing Services offers flexibility aligned with market demand, provides continuous supply of services, mitigates the risk and reduces the overall operational cost of a company. These factors are expected to, furthermore, drive the growth of Electronic Manufacturing Services market.

The decline in the adoption of Personal Computers (desktops, notebooks, etc.) is one of the major factors challenging the growth of Electronic Manufacturing Services market.

Electronic Manufacturing Services Market

Key Players

Some of the key players in the Electronic Manufacturing Services market are Benchmark Electronics, Inc., Creation Technologies LP, Celestica Inc., Venture Corporation Limited, Sparqtron Corporation, NATEL ENGINEERING CO., INC., API Technologies Corp, FLEX LTD., Foxconn Electronics Inc. and Integrated Micro-Electronics, Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Competition Analysis – Regional Trends:

The Electronic Manufacturing Services landscape is marked by intense competition on a global scale. Leading players in regions such as North America, Europe, Asia-Pacific, and Latin America are vying for market dominance. Asia-Pacific, in particular, stands out as a frontrunner in the market, owing to its robust manufacturing infrastructure, skilled labor force, and favorable regulatory environment. North America and Europe, while mature markets, continue to play a significant role in shaping industry trends through technological advancements and innovations.

In May 2022- Ohio. Hon Hai Technology Group (“Foxconn”), signed a contract with Lordstown Motors Corp. (“Lordstown Motors” or “LMC”) for a manufacturing agreement and a joint venture agreement for product development.
In August 2021, Toronto-based contract electronics manufacturer Celestica Inc. marked the grand opening of its AbelConn Electronics facility in Maple Grove, Minn, a wholly-owned subsidiary of Celestica. The facility provides rapid prototyping, volume manufacturing, and engineering support for the defense and aerospace industries.
In August 2022, Taiwanese electronics giant Foxconn is looking at making electric vehicles in India, part of a larger diversification plan to expand its Asian manufacturing supply chain beyond China, according to people aware of developments at the contract phone maker for Apple.

Request for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-5870

Key Segments Covered in the Electronic Manufacturing Services Industry Analysis

Electronic Manufacturing Services Market by Industry:

Electronic Manufacturing Services for Medical and Healthcare
Electronic Manufacturing Services for Defence and Aerospace
Electronic Manufacturing Services for Industrial Applications
Electronic Manufacturing Services for IT and Telecommunication
Electronic Manufacturing Services for Other Applications

Electronic Manufacturing Services Market by Region:

North America Electronic Manufacturing Services Market
Latin America Electronic Manufacturing Services Market
Europe Electronic Manufacturing Services Market
Asia Pacific Electronic Manufacturing Services Market
Middle East & Africa Electronic Manufacturing Services Market

Take the Next Step: Buy Our Exclusive Report for Informed Decisions : https://www.futuremarketinsights.com/checkout/5870

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Stoma Ostomy Care Market Set to Bloom at 4.9% CAGR, Reaching US$6.5 Billion by 2033 | FMI Analysis

The Stoma Ostomy Care Market is flourishing, driven by an aging population and the growing need for specialized healthcare solutions. According to a recent market analysis, the market reached a value of US$3.8 billion by the end of 2022. This positive trend is expected to continue, with the market projected to maintain a steady growth trajectory at a Compound Annual Growth Rate (CAGR) of 4.9% from 2023 to 2033. By leveraging this momentum, the industry is anticipated to reach a staggering valuation of US$6.5 billion by 2033.

Several significant factors contribute to the remarkable growth trajectory of the stoma care market. The increased prevalence of disorders that require ostomy care, combined with continual developments in surgical techniques and ostomy supplies, has played a critical part in accelerating this considerable expansion. Furthermore, increased awareness and advantageous reimbursement policies have provided a conducive atmosphere for the market’s continued expansion.

Among the most prevalent conditions requiring ostomy care are colorectal cancer, bladder cancer, and inflammatory bowel disease (IBD). These medical conditions often demand surgical intervention, such as surgical excision of aggressive melanoma of the intestine. In certain instances, patients require ostomy procedures, which involve the creation of a surgical incision through the abdomen to establish a new waste minimization conduit.

As we move forward, the stoma care market is poised to provide vital support and innovative solutions for individuals facing these medical challenges, contributing to improved healthcare outcomes and quality of life.

Request a Sample Copy of This Report Now.
https: www.futuremarketinsights.com reports sample rep-gb-14261

The adoption of stoma ostomy care procedures has increased worldwide due to the rising occurrence of these diseases and increased exposure to risk factors such as changing eating habits and increased antibiotic use in children.

However, despite recent advancements, the stoma ostomy market faces several constraints that limit its growth potential. These include stoma care issues, discomfort and other concerns associated with ostomy products, societal stigma, and increased acceptance of alternative therapies, particularly in developing countries.

While stoma surgeries are generally safe, there are some risks involved, including life-threatening issues such as necrosis and exhaustion. As a result, the acceptance of stoma care appliances may be limited to some extent.

Stoma Ostomy Care Market Key Takeaways:

The USA market will hold a market share of around 28.7% in the 2023 global market.
Germany is set to hold around 5.3% of the global market share in stoma ostomy care in 2023.
The Indian market is projected to expand at a CAGR of 3.8% during the forecast period.
Due to a growing number of patients suffering from target diseases such as colorectal cancer, Ostomy Bags is predicted to occupy a considerable revenue share of 84.3% in the global market by 2023.
Due to the rising frequency of IBD, bowel cancer, and colon cancer in both developed and developing nations, as well as the favorable reimbursement environment in developed countries, the colostomy sector is predicted to hold a high market share of 88.8% in the global market in 2023.

“Improvement in product design will remain a key differentiator as end users have to face stigma with the drainage bags,” reports an FMI analyst.

Grab Your Discount Now Before It’s Gone!
https: www.futuremarketinsights.com request-discount rep-gb-14261

Stoma Ostomy Care Market Competitive Landscape

The European market for stoma ostomy care is the largest. However, according to recent trends, key players are focusing on the Asia Pacific market due to low labor costs and a large pool of patients.

Coloplast Singapore released SenSura Mio in February 2022, which uses the latest elastic adhesive technology and is appropriate for all peristomal body profiles. SenSura® Mio is being offered in Singapore for the first time in Southeast Asia to improve the quality of life for ostomytes, or those who have had an ostomy and now have a stoma.
Trio Healthcare received financing from SWK Holdings Corporation, a specialized finance company based in the United States, in February 2020, to accomplish significant local and global expansion ahead of an anticipated product launch in 2021.

Key Players in the Stoma Ostomy Care Market

BAE Systems Plc, ConvaTec Inc., Hollister Inc., EuroMed, Inc, 3M Company, Smith & Nephew plc, FNC Medical, Nu–Hope Laboratories, Inc., Marlen Manufacturing & Development Co., Torbot Group, Inc, Cymed Micro Skin, Alcare Co., Ltd., B. Braun Melsungen AG., Salts Healthcare Ltd, Securi–T USA., Welland Medical Limited, Flexicare Group Limited.

More Insights Available

North America is expected to dominate the stoma care market, owing to the high incidence of colorectal cancer and inflammatory bowel disease in the region, as well as the high adoption rate of advanced stoma care products. The United States is the largest market in North America, followed by Canada.

Get Your Customized Impactful Report Now!
https: www.futuremarketinsights.com customization-available rep-gb-14261

Stoma Ostomy Care Market Key Segments

By Surgery Type:

Colostomy
Ileostomy
Urostomy

By Product:

Ostomy Bags
Ostomy Accessories
- Belts & Tapes
- Skin Protection &Skin Barrier
- Irrigation Sets
- Convex Inserts
- Stoma Caps

By Application:

Cancer
Inflammatory Bowel Disease
Bowel Obstruction
Fecal Incontinence
Trauma and Infection

By End–Users:

Hospitals and Specialty Clinics
Home Care Settings
Ambulatory Surgical Centers

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https: www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Peptide Synthesis Market Booming at 8% CAGR, Set to Reach US$1.1 Billion by 2033 | FMI Study Report

The Peptide Synthesis Market is experiencing a surge in growth, driven by its increasing importance in both research and therapeutic applications. According to a recent market analysis by Future Market Insights (FMI), a leading market research firm, the market is poised for a significant expansion. Currently valued at an estimated US$520.0 million in 2023, the market is projected to climb steadily at a Compound Annual Growth Rate (CAGR) of 8%. This positive trajectory indicates a bright future for the peptide synthesis industry, with a projected valuation reaching an impressive US$1.1 billion by 2033.

The rising prevalence of metabolic illnesses and chronic diseases such as diabetes, oncology, and obesity is driving this unprecedented growth. This development emphasizes the crucial need for novel medical solutions, with peptide synthesis emerging as a key component. Its broad chemical diversity, powerful biological activity, and low toxicity make it an ideal choice for the development of cutting-edge healthcare solutions.

The market’s expansion is further fueled by the escalating demand for pharmacological components in medication. As the need for treatments targeting cardiovascular, neurological, and renal failures continues to grow, the significance of peptide synthesis in the pharmaceutical landscape becomes increasingly evident.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-14257

Governments’ initiative programs, advanced healthcare therapy with adopting the latest technology, and research and development activities are further surging the market opportunities.

Rising consumer healthcare and pharmaceutical sectors are increasing the demand for peptide synthesis. Moreover, the growing malignancies, uneven lifestyles, and deadly diseases propel market opportunities. Due to its effective result, the growing popularity of enzymatic technology upsurges market growth among patients.

How Key Players Faced Threats in the Peptide Synthesis Market?

Due to the lack of a peptide purification system, several therapeutic peptides go through the parenteral route. The adoption of peptide synthesis medications are widely used to treat a chronic illness for a long period of treatment, may face a problem for key players. Enzymatic breakdown and limited intestinal mucosa are a few causes of adopting oral peptide drugs.

These medicines have poor lipophilicity and charged functional groups, which are difficult to handle or absorb. However, several peptide synthesis companies are given that peptides have short half-lives and limited bioavailability. Fast metabolism and conformational changes restrict protein therapies and the bioavailability of peptides.

Pharmaceutical and Biotechnology Sectors Leading the Market Growth

Growing research and development activities, low-cost therapies, and efficient and low toxicity are a few important factors that propel market growth. The significantly growing advanced technology in the pharmaceutical and biotechnology sectors is driving peptide synthesis market expansion.

In 2022, according to Science Direct, advanced oral drugs treated diabetes patients through peptide medications. Moreover, in Jan 2022, Novo Nordisk launched its new and world’s first diabetes management ‘peptide in a pill’.All these developments are boosting the pharmaceutical and biotechnology sectors.

Increasing Patients of Chronic Disease Dominates the United States Market

The United States is leading the global market by capturing an impressive CAGR of 7.8% during the foreseen time. Increasing chronic patients, including cardiovascular and diabetes, are fostering market growth. The rising demand for peptide-based vaccines is increasing the demand for peptide synthesis.

According to a report by the American Cancer Society, around 1.9 million new cancer cases grew in the United States. The innovation of new drugs, rising government policies, and new market entrance are surging the United States peptide synthesis market opportunities.

Peptide Synthesis Market Key Takeaways:

The peptide synthesis market is expected to have a valuation of US$ 1.1 billion by 2033.
With a CAGR of 8%, the global market increasing from 2022 to 2033.
The United States peptide synthesis market is anticipated to record a CAGR of 7.8% through 2033.
With a CAGR of 7.1%, the United Kingdom market significantly uplifts during the forecast period.
China’s market is expected to hold a CAGR of 7.4% over the forecast period.
Japan’s market captured a CAGR of 6.5% from 2023 to 2033.

Peptide Synthesis Market Competitive Landscape:

The present prominent players fragmented the market. These players invested a huge amount in research and development activities to acquire maximum output. Through their marketing strategies, these prominent players upsurge the market growth.

Peptide Synthesis Market Key Players:

GenScript Biotech Corporation
Bachem Holding AG
Thermo Fisher Scientific Inc
Merck KGaA
Kaneka Corporation

Level Up Your Market Understanding – Purchase Now!
https://www.futuremarketinsights.com/checkout/14257

Peptide Synthesis Market Recent Developments:

In June 2020, Evonik announced its new peptide, which is highly soluble and chemically defined to supply amino acids.
In May 2022, the United States Food and Drug Administration approved the Mounjaro injection that helps to control blood sugar and type 2 diabetes disease.

Peptide Synthesis Market by Category

By Product and Services:

Reagents
Equipment
Services

By Technology:

Solid-phase peptide Synthesis
Solution-phase Peptide Synthesis
Hybrid & Recombinant Technology

By End Use:

Pharmaceuticals & Biotechnology Companies
CDMOs & CROs
Academics & Research Institutes

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Medical Rehabilitation Robotics Market Gears Up for 15.2% CAGR, Reaching US$1.76 Billion by 2033 | FMI Study

The Medical Rehabilitation Robotics Market is poised for a significant transformation, fueled by continuous advancements in technology and a growing demand for innovative solutions in physical therapy. According to a recent market analysis by Future Market Insights (FMI), a leading market research firm, the market is currently valued at US$366.2 million in 2022. However, it is projected to experience a robust Compound Annual Growth Rate (CAGR) of 15.2% over the next decade. This positive trajectory is expected to propel the market to reach an impressive US$1.76 billion by 2033.

In combination with this expansion, the Pediatrics Rehabilitation Robotics Market, while still in its early phases, promises a promising future. The expansion of rehabilitation services for patients with diseases like autism and cerebral palsy is projected to be a key driver of market growth.

One of the highlights of medical rehabilitation robotics is its myriad of benefits, particularly in affording individuals with spinal cord injuries the opportunity to stand and walk at a reduced metabolic cost. Moreover, this industry is at the forefront of technological advancements, incorporating Machine Learning (ML) and Artificial Intelligence (AI) alongside advanced sensor technologies. The burgeoning geriatric population further propels the exponential growth of the medical rehabilitation robotics industry.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-14242

Along the above-mentioned lines, PARO comes across as a companion robot that has been specially designed for those suffering from Alzheimer’s, dementia, and various other cognition disorders. Dr. Takanori Shibata from Japan’s National Institute of Advanced Industrial Science and Technology has come up with this assistive robot for helping those with disabilities fulfill daily activities like eating and walking. The robotic lower-body exoskeleton is being used to assist the ones with paralysis of the lower limbs and does encourage muscle activity therein.

Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Medical Rehabilitation Robotics Market’ with its team of analysts and consultants deploying a 360-degree view in its primary, secondary, and tertiary modes of research.

“With Spike in cases of stroke, the global medical rehabilitation robotics industry is expected to go great guns shortly”, says an analyst from Future Market Insights.

Key Takeaways from the Medical Rehabilitation Robotics Market

North America holds more than 40% of the market share due to growing incidences of spinal cord injury followed by a rising aging and disabled population.
Europe holds a significant market share with Germany leading from the front with Spain, Denmark, and the UK leading from the front.
The Asia-Pacific is expected to grow at a rapid pace in the medical rehabilitation robotics industry with countries like Japan obtaining the status of ‘super-aging society’.

Competitive Robotics

Ekso Bionics Holdings, Inc. received approval from the US FDA for marketing the EksoNR robotic exoskeleton for usage with patients suffering from MS (Multiple Sclerosis).
Tyromotion, late, completed the acquisition of Band Therapy AG (a Swiss-based start-up) to encourage patients’ ownership of recovery with cutting-edge movement trackers.
Bionik Laboratories Corporation, in January 2019, launched the InMotion ARM/HAND robotic system to clinically rehabilitate stroke survivors and the ones having mobility impairments owing to neurological conditions. The enhanced robotic system has been developed according to principles of motor learning as well as neuroplasticity and makes use of AI and data analysis for offering individualized therapy to patients.
ReWalk Robotics, Inc., in June 2019, announced that the US FDA approved the ReStore soft exo-suit system for selling to rehabilitation centers all over the US.
Cyberdyne Inc., in January 2018, obtained approval from the US FDA to sell HAL (Hybrid Assistive Limb) lower-body exoskeleton in licensed medical facilities all over the US.
Stryker Corporation, in the year 2020, did receive regulatory approval for the MAKO robotic surgery system in Japan for partial knee indication.
Accuracy, in 2020, did launch the CyberKnife S7 System, which comes across as a next-generation CyberKnife platform with real-time, advanced, AI-driven motion tracking as well as synchronization treatment delivery for SBRT (stereotactic body radiation therapy) and SRS (stereotactic radiosurgery).
Medtronic, in 2020, completed the acquisition of Medicrea through AI, patient-specific implants, and predictive modeling.
Intuitive Surgical, in 2019, did receive clearance from the US FDA regarding the da Vinci Single-port Surgical System.

Key Medical Rehabilitation Robotics Market Players:

Ekso Bionics Holdings Inc.
AlterG Inc.
Bionik Laboratories Corp.
Cyberdyne Inc.
Rewalk Robotics.
Instead Technoligies Ltd.
Hocoma AG.
Fourier Intelligence
Tyromotion Gmbh
Toyota Motor Corporation
BeatBots LLC
Bioxtreme
Rex Bionics Inc.
LEADERS REHAB ROBOT Co. Ltd.

Click Here Today To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/14242

Key Segments Covered in Medical Rehabilitation Robotics Market Research

By Product:

Exoskeletons
Therapeutic/ Assistive

By Extremity:

Upper Extremity
- Arm
- Wrist
- Shoulder
- Elbow
Lower Extremity

By Therapy:

Limb Mobility
Gait
Sensory

By Patient:

Adults
Pediatric

By Application:

Neurorehabilitation
Physical Rehabilitation
Others

By End-user:

Hospitals
Wellness centers
Rehabilitation centers
Homecare

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Cold Disposable Biopsy Forceps Market to US$1.4 Billion by 2033 at a 8.2% CAGR Driven by Minimally Invasive Procedures

The Cold Disposable Biopsy Forceps Market is experiencing a surge, fueled by the growing preference for minimally invasive procedures in healthcare. According to a recent market analysis by Future Market Insights (FMI), a leading market research firm, the market is anticipated to reach a remarkable valuation of US$1.40 billion by 2033. This optimistic forecast signifies a strong upward trajectory, following the market’s impressive performance with an estimated value exceeding US$634.6 million by 2023. Propelling this growth is a compelling Compound Annual Growth Rate (CAGR) of 8.2%.

The surge in demand for cold disposable biopsy forceps is attributed to several factors, including the increasing prevalence of bronchitis and gastrointestinal disorders, particularly among the geriatric population. Additionally, a heightened awareness of endoscopic procedures is contributing to the market’s upward trajectory. The adoption of disposable biopsy forceps, known for their reliability in test sampling, is also expected to gain widespread popularity.

The current landscape sees minimally invasive technology, centered around the endoscope system, extending its reach to various medical departments, including obstetrics, general surgery, otolaryngology, gynecology, thoracic surgery, urology, pediatrics, and more. Minimally invasive endoscopic technology has become indispensable for the diagnosis and treatment of chronic diseases associated with breathing, digestion, urology, otolaryngology, and beyond.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14240

With the rising demand for endoscopic minimally invasive technology and continuous improvement in endoscopic processing technology, endoscopic applications have become prominent in almost all departments. The growing demand for diagnosis and endoscopic treatment is expected to further boost the demand for cold disposable biopsy forceps.

Numerous recent technological advances are becoming available to endoscopists. An abundance of new imaging modalities is expected to facilitate early detection of chronic disorders and other pathological entities. Most of these techniques remain investigational and are currently in clinical trials to determine patient benefits.

Companies are expanding their product lines by manufacturing different types of products for a wide range of applications.

For instance, Micro-Tech Endoscopy is mainly engaged in the R&D, manufacturing, and sales of minimally invasive medical devices, in line with its mission of supporting clinicians with technology and innovation.

Key Takeaways from Cold Disposable Biopsy Forceps Market Study

Oval cup forceps gained popularity and their sales are expected to grow at a CAGR of 8.8% during the forecast period.
8 mm diameter has sharpened cups which ensure superior cutting performance and lead to fewer artifacts and less bleeding. The segment is therefore expected to account for a share of 24.9% in 2021.
2300 mm length forceps have precise jaws, no tearing, and cause small wounds. The segment accounted for the highest share of 37.9% in 2021.
Upper GI Endoscopy dominated the application segment with the highest market share of 24.9% in 2021.
Hospitals accounted for the largest share of around 42.0% in 2021 and will remain the end user in the market.

“High prevalence of conditions such as IBD and GERD and growing demand for minimally invasive endoscopic procedures are set to boost the demand for Global Cold Disposable Biopsy Forceps Industry over the next decade,” says the Future Market Insights analyst.

Who is winning?

The key players are focusing on acquisitions and partnerships with small players and suppliers to increase their market presence. Besides this, they are adopting various strategies to expand their footprint. For instance:

iIn April 2018, Boston Scientific Corporation closed its acquisition of NxThera. The company developed a minimally-invasive therapy the Rezūm system, for patients suffering from symptomatic benign prostatic hyperplasia. With the completion of the acquisition, NxThera became a part of Boston Scientific’s urology and pelvic health business. Moreover, the manufacturers are focusing on research and development activities for developing cold disposable biopsy forceps for various research applications.

In july 2020, ChargePoint and STERIS collaborated to develop a fully validated sterile transfer solution to offer a unique and integrated solution for sterile product transfer.

Some of the leading players in the Global Cold Disposable Biopsy Forceps Industry include but are not limited to Olympus Corporation, Boston Scientific Corporation, STERIS, CONMED Corporation, Cook Medical, Micro-Tech Endoscopy, Anrei Medical, and other companies.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/14240

Key Segments Covered in Cold Disposable Biopsy Forceps Market Research

By Product:

Oval Cup
Oval Cup with Needle
Alligator Jaw
Alligator Jaw with Needle

By Diameter Size:

By Length:

1150mm
1550mm
2300mm

By Application:

Enteroscopy
Upper GI Endoscopy
Lower GI Endoscopy
Bronchoscopy
Others

By End User:

Enteroscopy
Upper GI Endoscopy
Lower GI Endoscopy
Bronchoscopy
Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Manometry System Market Set for Steady Growth at 5.4% CAGR, Reaching US$311.64 Million by 2033 | FMI Study

The Manometry System Market is on track for a significant expansion, driven by the rising demand for precise diagnoses of digestive disorders. According to a recent market analysis, the market is currently projected to generate US$184.18 million in sales by 2023. This positive trend is expected to continue, with the market flourishing at a Compound Annual Growth Rate (CAGR) of 5.4% and reaching an impressive US$311.64 million by 2033.

This phenomenal expansion is being driven by several significant variables influencing the landscape of the manometry system business. A large increase in the incidence of fecal incontinence and constipation, combined with an aging worldwide population, is driving the market’s increasing trend. Furthermore, continuing technical developments and ongoing healthcare infrastructure development are critical to the industry’s success.

The surge in cases related to constipation, fecal incontinence, anorectal pain, pelvic floor dyssynergia, and Hirschsprung’s among the elderly population is fueling the adoption of manometry systems. The increasing demand for these systems stems from their ability to evaluate patients, providing valuable data on anorectal function and indicating the prognosis of treatment, especially in managing sphincter injuries.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14110

Rising demand for non-invasive equipment is driving the demand for manometry systems. These systems are non-invasive diagnostic procedures that can detect pressures and sensations in the anus and rectum. With this, they indicate whether the patient’s pelvic function is normal without incision into the body or removal of tissue and has low risks, and complications.

Further, rising government initiatives and funding supporting the development of products are boosting the demand for the Global Manometry System Industry. Initiatives undertaken by the government to enable and boost the ecosystem for the indigenous medical device industry are also stimulating market growth.

“As demand for manometry systems is rising due to high prevalence of gastrointestinal diseases, key players are engaging in product development that is technologically advanced for faster approvals. This is expected to give the key players a competitive edge in the industry, generating revenues,” says the FMI Analyst

Key Takeaways from the Manometry System Market Study

By product, system sheaths & catheters are expected to account for the largest share of 0% in 2021.
In terms of portability, the stand-alone system will hold the largest share of 4 in 2021 on the back of its enhanced sensitivity to provide accurate diagnosis of the condition
By end user, hospitals accounted for the largest share of 9 in 2021 owing to the rising demand for hospital stays that is short-term and an increasing number of gastrointestinal processes.
North America is expected to hold the largest share of 38.9% in 2021 with the U.S. leading the market during the forecast period.

Who is Winning?

Some of the leading manufacturers of the manometry system market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

Several joint ventures, agreements, and loan licensing procedures have influenced the market. The government of developing economies has taken several reforms to develop the market by regulating it to bring out more transparency and by allowing foreign investments in the industry.

New Product launches & approvals have emerged as key growth strategies adopted by the leading players in the manometry system market. Following this, the acquisition was the second most key strategy adopted by the industry players. By adopting these strategies, it helped the company to expand its regional presence as well as product offerings.

For instance,

In October 2021, “UROTECH GmbH subsidiary of Medi-Globe Group provided detailed information on a new clinical study for using the Magnetic Black-Star® (MBS) in pediatric urology. The MBS was an innovative product of UROTECH GmbH, which is used in stent placement as well as stent removal of children without performing the surgeries using the stent’ magnetic tip.”
In May 2020, RMS Medical Devices proudly announced its acquisition of QUICKORE products for BENELUX. With this new acquisition, RMS Medical Devices adds another premium technology to its Radiology portfolio.
In October 2020, LABORIE Medical Technologies entered into a strategic partnership with Urotronic to support regulatory approval of Optilume, a drug-coated balloon (DCB) technology for use in urethral strictures and benign prostatic hyperplasia (BPH).
In August 2021, Medtronic Announced the FDA Approval of the Next-Gen TAVR System for the treatment of symptomatic severe aortic stenosis. Next-Gen TAVR System is a self-expanding transcatheter aortic valve replacement, which is designed to enhance ease of use and predictable valve deployment throughout the procedure.

The key market players covered by FMI include EB Neuro S.p.A, MEDSPIRA, Medtronic, Medica S.p.A., RMS Medical Devices, MARQUAT Génie Biomédical, Diversatek Inc., Dentsleeve International Ltd., LABORIE, Prometheus Group, Smart Medical Group, Synectics Medical Limited, Medovations Inc., Sierra Scientific, and Urotech Gmbh.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/14110

Key Segments of the Manometry System Market by Category

Product:

Anorectal Manometry System
Anorectal Manometry System Software
Anorectal Manometry System Sheath & Catheters

Portability:

Stand Alone System
Portable System

End User:

Hospitals
Diagnostic Centers
Specialty Clinics
Academic Research Institutes

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nasal Antihistamines Market Set to Reach US$3.23 Billion by 2033 at 4.6% CAGR | FMI Study Report

The Nasal Antihistamines Market is poised for a significant rise, offering welcome relief to allergy sufferers worldwide. Driven by a growing prevalence of allergies and the convenient nature of nasal delivery, the market is projected to experience steady expansion.

According to a recent market analysis, the industry, currently valued at an estimated US$2.06 billion in 2023, is anticipated to climb at a compelling Compound Annual Growth Rate (CAGR) of 4.6%. This upward trajectory is expected to propel the market to reach a significant milestone of US$3.23 billion by 2033.

Antihistamines, renowned for their effectiveness in alleviating allergy symptoms, have become a focal point in the pharmaceutical landscape. These medications play a pivotal role in addressing issues stemming from an excess of histamine—a natural substance produced by the immune system. Individuals suffering from allergies, particularly those triggered by pollen and various allergens, have wholeheartedly embraced antihistamines to find relief from symptoms such as sneezing, congestion, and itchy, runny noses.

Over the past three decades, the global prevalence of respiratory diseases—including allergic rhinitis, chronic obstructive pulmonary disease, and asthma—has surged. According to a report published by the National Center for Biotechnology Information (NCBI), approximately 20–30% of the Indian population grapples with allergic rhinitis, with 15% eventually developing asthma¹.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-13708

Due to this growing burden, there has been an increased adoption rate of nasal antihistamines in the form of nasal sprays and nasal drops, globally. The nasal antihistamines provide rapid and effective relief from the symptoms of allergic rhinitis. Thus, the growing number of allergic rhinitis cases will propel the growth of the Global Nasal Antihistamines Industry in the future.

Advancements in the field of nasal drug delivery have enabled the establishment of several non-invasive approaches for treatment. Various new products such as metered dose delivery systems, innovative odorless powders and sprays, preservative-free nasal sprays, and others are key drivers that will expand this industry in the forecast period.

FDA approvals of various nasal sprays to switch from prescription to OTC use have led to increased independence concerning the self-administration of drugs, among patients who suffer from allergic rhinitis. Various additions by the manufacturers to the already available product lines, especially for AR are some of the techniques used by the manufacturers to increase product penetration amongst the population.

New product launches & approvals have emerged as key growth strategies adopted by the leading players in the Global Nasal Antihistamines Industry. Following this, the acquisition was the second most key strategy adopted by the industry players. By adopting these strategies, it helped the company to expand its regional presence as well as product offerings.

For instance, In December 2020, GlaxoSmithKline launched Otrivin Breathe Clean, a saline wash with the moisturizing benefit of natural glycerine as a product for the symptomatic relief of allergic rhinitis.

Such developments not only strengthen the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and help companies to sustain the increasing competitive pressure.

Key Takeaways from Nasal Antihistamines Market Study

By product, nasal sprays accounted for the largest share of 89.0% in 2021 and are expected to continue to grow at the same trend during the forecast period.
By age group, adults accounted for the largest share in 2021 of the nasal antihistamines market and are expected to continue to grow at the same trend during the forecast period.
By distribution channel, the retail pharmacies segment is expected to account for the largest share of 41.0% in 2021 of the nasal antihistamines market and is expected to continue to grow at the same trend during the forecast period.
By region, East Asia held 23.0% in 2021 of the nasal antihistamines market. The growing awareness regarding allergies and developing healthcare infrastructure are some factors fueling this region’s high market share.

Who is Winning?

Some of the leading manufacturers of the Global Nasal Antihistamines Industry are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

In April 2021, Merck & Co. acquired Pandion Therapeutics, Inc which is a U.S.-based clinical-stage biotechnology company for US $1.85 Bn. With this acquisition, Merck strategizes to identify and secure candidates with differentiated and potentially found characteristics for the clinical trials required for their new product launches. This will ensure smooth conduction of clinical trials and thus help the company to expand its business.
In April 2020, Cipla received final approval from the United States FDA for a generic version of Proventil® HFA Inhalation Aerosol. With this approval, the company strengthened its presence in the US pharmaceutical market

The key market players covered by FMI include Bayer Healthcare LLC, Novartis International AG, Cipla, Glenmark Pharmaceuticals, GlaxoSmithKline, Sun Pharmaceuticals, Merck & Co., Centaur Pharmaceuticals, Viatris (Meda Pharmaceuticals), Proctor & Gamble, Ascend Laboratories LLC (Alkem Laboratories), J Pharmaceuticals, Alistair Pharmaceuticals, and Sato Pharmaceuticals.

Purchase a Complete Research Report
https://www.futuremarketinsights.com/checkout/13708

Nasal Antihistamines Market by Category Product:

Nasal Spray
Nasal Drops

Age Group:

Adult
Pediatric

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Hydration Supplement Market Growth Valued at USD 82.7 Billion by 2034 | FMI

According to Future Market Insights’ latest report, sales of hydration supplements are forecast to total USD 36.0 billion in 2024 and further soar at 7.9% CAGR. Accordingly, the total market valuation is set to reach USD 82.7 billion by 2034.

Sports drinks are predicted to remain top-selling products. This can be attributed to their growing popularity among athletes and fitness freaks due to their convenience and targeted functionality. The target segment is forecast to record a CAGR of 7.7% through 2034.

Hydration Supplement Market Growth — Hydration Supplement Market

Request Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-19345

Several factors are driving the demand for hydration supplements. These include rising awareness of the importance of hydration on health and well-being, growing fitness and wellness trends, and the availability of a wide range of hydration supplements in different formats.

Hydration supplements, including electrolyte drinks, are becoming highly popular among athletes and fitness enthusiasts for replenishing electrolyte levels lost during physical activity. As a result, their demand is growing rapidly, and the trend is set to continue through 2034.

People across the world are becoming aware of the importance of hydration on physical performance and cognitive health. This is resulting in higher consumer interest in hydration supplements, including electrolyte powders and sports drinks, thereby boosting sales growth.

Many consumers are seeking natural and plant-based hydration products due to concerns about artificial additives and synthetic ingredients. This is prompting manufacturers to develop novel hydration supplements using natural and plant-based ingredients.

Marketing campaigns and celebrity endorsement also play an important role in uplifting the demand for hydration supplements. Similarly, the rising penetration of e-commerce is having a positive impact on the growth of the hydration supplement market.

Key Takeaways – Global Hydration Supplement Market:

The global hydration supplement marketis set to total US$ 82.7 billion in 2034.
By product type, the sports drinks segment will exhibit a CAGR of 7%.
Based on sales channel, the online pharmacies segment is forecast to advance at 6% CAGR.
North America is set to hold a dominant value share of 2% by 2034.
Hydration supplement demand in China is forecast to rise at 6% CAGR.
India is becoming a highly lucrative market, recording a CAGR of 4%.

“Longer term trends, including shifting consumer preferences towards natural and herbal components, a willingness to pay more for premium hydration supplements, and an aging population, are set to present lucrative growth prospects to hydration supplement manufacturers through 2034.” – says a lead analyst at Future Market Insights (FMI).

Request Your Customizable Report:
https://www.futuremarketinsights.com/customization-available/rep-gb-19345

Key Players – Global Hydration Supplement Market:

The hydration supplement market has a diverse and dynamic competitive landscape. Leading hydration supplement manufacturers listed in the report include Gatorade (PepsiCo), Powerade (The Coca-Cola Company), GU Energy Labs, SOS Hydration, Liquid I.V., DripDrop, and Tailwind Nutrition, and Skratch Labs.

Top companies are strengthening their portfolios through new product launches featuring natural ingredients and eco-friendly packaging. They also use strategies like celebrity endorsements, partnerships, advertisements, acquisitions, and distribution agreements to stay ahead of the competition.

Recent Development – Global Hydration Supplement Market:

In 2024, Design to Health introduced a new product in the hydration supplement, “ElectroPure Hydration™.”

Want More Insights?

Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global hydration supplement market, presenting historical demand data (2019 to 2023) and forecast statistics for the period from 2024 to 2034.

The study incorporates compelling insights on the hydration supplement industry based on product type (electrolyte tablets or powders, sports drinks, hydration powders or mixes, electrolyte drinks, coconut water, and hydration gels), application (sports nutrition, active lifestyle, health & wellness, and medical conditions), and sales channel (store-based retails and online pharmacies) across various regions.

Get Full Report Now:
https://www.futuremarketinsights.com/checkout/19345

Key Segmentation – Global Hydration Supplement Market:

By Product Type:

Electrolyte Tablets or Powders
Sports Drinks
Hydration Powders or Mixes
Electrolyte Drinks
Coconut Water
Hydration Gels

By Application:

Sports Nutrition
Active Lifestyle
Health & Wellness
Medical Conditions

By Sale Channels:

Store-based
- Modern Trade
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
Online Pharmacies

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

About Future Market Insights (FMI)

Contact FMI:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube